New England Journal of Medicine· 2015Q1· Clinical trial

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes

Christopher P. Cannon, Michael A. Blazing, Robert P. Giugliano, Amy McCagg et al.

4,433citations
Q1SCImago
2015year

Short summary

Adding ezetimibe to statin therapy in patients hospitalized for acute coronary syndromes further reduced cardiovascular events by 7% compared to statin monotherapy over a median of 6 years.

AI-generated from the title and abstract; the full text is not read.

TakeawaysIn the app

Key pointsIn the app

Ask the paperIn the app

The rest is in the Pofolia app

Takeaways, key points and questions to the paper; new summaries every day for your field. Free.

Get it on Google Play Download on the App Store

Field: Surgery

SurgeryMedicine